Understanding differences among preparations and dilutions of botulinum toxin type A can improve clinical practice, according to industry experts.
Whitney J. Palmer
A new systemic medication option offers promising results for patients with high-risk squamous cell carcinoma for whom surgery has not worked, says this expert.
Anneke Andriessen, Ph.D. discusses research that suggests controlling symptoms with moisturizers can be an important — and inexpensive — prevention and treatment tactic for pediatric patients with atopic dermatitis.
As one of the most common dermatological conditions of childhood, atopic dermatitis affects between 10% and 20% of pediatric patients.
A variety of topical CBD products are becoming increasingly available to patients, but do they actually work? These experts believe more research is needed to create CBD-containing dermatology products that can effectively treat skin disorders.
Many patients living with hyperhidrosis do so silently, meaning the condition is often left untreated. It's up to dermatologists start the conversation about available treatments when they notice patients’ symptoms, say this expert.
Clinical trials investigating the efficacy of biologics in treating this condition at Stage 2 and Stage 3 are growing in number and should be considered a front-line treatment option, says this expert.
Dr. Susan Weinkle offers tips to minimize discomfort, which plays a large role in the patient’s perception of outcome.
Dr. Scott Dinehart discusses two newer methods for attacking squamous cell carcinoma, which he says are critical to know.
Radiodermatitis affects approximately 95% of all patients who receive radiation therapy for cancer - many of who are women undergoing breast cancer treatment. A recent study has found that developing the condition has a significant and detrimental impact on breast cancer patients' overall quality-of-life.